“Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes: A Systematic Review and Meta-Analysis
Stem cell transplantation (SCT) has paved the way for treatment of autoimmune diseases. SCT has been investigated in type 1 diabetes mellitus (T1DM) as an autoimmune-based disorder, but previous studies have not presented a comprehensive view of its effect on treatment of T1DM.
Concise Review: Mesenchymal Stem Cells for Diabetes
Because of their ease of procurement and differentiation into a variety of connective tissues, MSCs have taken an early lead over other stem cell types and as such are highly represented in ongoing clinical trials for a variety of conditions including diabetes.
Stem cells in the treatment of diabetes mellitus — Focus on mesenchymal stem cells
This study in Science Direct reviews how different types of stem cells can treat diabetes.
Stem Cell Therapy for Ulcerative Colitis: A Promising Approach
Inflammatory bowel diseases (IBDs) represent a group of chronic inflammatory disorders of the gastrointestinal (GI) tract including ulcerative colitis (UC), Crohn’s disease (CD), and unclassified IBDs.
Mesenchymal Stem Cells (MSCs) in Therapy for Colitis
In recent years, mesenchymal stem cells (MSCs)-based therapy has emerged as a promising strategy for the treatment of IBDs due to their potent immuno-modulatory and tissue-repair functions
Mesenchymal Stem Cells for the Treatment of EBV-Induced Chronic Fatigue Syndrome: A Pilot Study
EBV-specific adoptive T cell therapy was well tolerated. Clinical improvement following treatment was associated with the potency of EBV-specific reactivity of the administered T cells. Further clinical trials are warranted to determine the efficacy of EBV-specific T cell therapy in MS.
Epstein-Barr Virus Emerging As Possible Cause of Chronic Pain
It is now clear that EBV must be contained and suppressed in order to relieve the pain and suffering of many persons with chronic pain. This column is an introduction to the critical involvement of EBV with several chronic pain conditions.
Stem Cells Hold Promise for Type 1 Diabetes Cure
Article from Harvard on Stem Cells and Diabetes
Novel cell therapy continues to show promise for Parkinson’s disease
UC David Study Shows Promise…This article reports on the 18-month results of a clinical trial for bemdaneprocel, a stem cell-derived therapy for Parkinson’s disease. The therapy showed positive results in safety, tolerability, and potential efficacy in restoring dopamine production.
UC Davis Health leads study on promising stem cell-based therapy for Crohn’s disease
This article details a study on human bone marrow-derived mesenchymal stem cells (hMSCs) for treating Crohn’s disease. The research showed promising results in mouse studies, demonstrating the potential of hMSCs to heal the intestinal lining and prompt a positive immunologic response.
Efficacy of stem cells therapy for Crohn’s fistula: a meta-analysis and systematic review
Study showed that stem cell group had a higher rate of fistula healing compared to placebo group in patients of Crohn’s fistula
MS patients are in sustained remission after stem cell transplantation
Registration
required to read the full study
Stem cell therapies: a new era in the treatment of multiple sclerosis
n recent advancements, stem cell therapy has been recognized as a frontier with significant potential in the treatment of MS. Stem cells, characterized by their inherent ability for self-renewal and pluripotency
Stem cell therapies: a new era in the treatment of multiple sclerosis
From NCBI published in May 2024
What’s New in MS Research – March 2024
Spring of 2024 research update from the MS Association of America.
